Targeting histone deacetylases: A novel therapeutic strategy for atrial fibrillation

Baigalmaa Lkhagva, Yu Hsun Kao, Yao Chang Chen, Tze Fan Chao, Shih Ann Chen, Yi Jen Chen

研究成果: 雜誌貢獻回顧型文獻同行評審

12 引文 斯高帕斯(Scopus)


Atrial fibrillation (AF) is a common cardiac arrhythmia associated with high mortality and morbidity. Current treatments of AF have limited efficacy and considerable side effects. Histone deacetylases (HDACs) play critical roles in the pathophysiology of cardiovascular diseases and contribute to the genesis of AF. Therefore, HDAC inhibition may prove a novel therapeutic strategy for AF through upstream therapy and modifications of AF electrical and structural remodeling. In this review, we provide an update of the knowledge of the effects of HDACs and HDAC inhibitors on AF, and dissect potential underlying mechanisms.
頁(從 - 到)250-257
期刊European Journal of Pharmacology
出版狀態已發佈 - 2016

ASJC Scopus subject areas

  • Pharmacology

指紋 深入研究「Targeting histone deacetylases: A novel therapeutic strategy for atrial fibrillation」主題。共同形成了獨特的指紋。